Works matching IS 00070920 AND DT 2012 AND VI 106 AND IP 4

Results: 32

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Published in:

2012

By:

Myklebust MP;
Fluge ø;
Immervoll H;
Skarstein A;
Balteskard L;
Bruland O;
Dahl O;
Myklebust, M P;
Fluge, Ø;
Immervoll, H;
Skarstein, A;
Balteskard, L;
Bruland, O;
Dahl, O

Publication type:

journal article

The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis.

Published in:

2012

By:

Follet J;
Corcos L;
Baffet G;
Ezan F;
Morel F;
Simon B;
Le Jossic-Corcos C;
Follet, J;
Corcos, L;
Baffet, G;
Ezan, F;
Morel, F;
Simon, B;
Le Jossic-Corcos, C

Publication type:

journal article

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.

Published in:

2012

By:

King MT;
Viney R;
Smith DP;
Hossain I;
Street D;
Savage E;
Fowler S;
Berry MP;
Stockler M;
Cozzi P;
Stricker P;
Ward J;
Armstrong BK;
King, M T;
Viney, R;
Smith, D P;
Hossain, I;
Street, D;
Savage, E;
Fowler, S

Publication type:

journal article

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

Published in:

2012

By:

Boni C;
Tiseo M;
Boni L;
Baldini E;
Recchia F;
Barone C;
Grossi F;
Germano D;
Matano E;
Marini G;
Labianca R;
Di Costanzo F;
Bagnulo A;
Pennucci C;
Caroti C;
Mencoboni M;
Zanelli F;
Prochilo T;
Cafferata MA;
Ardizzoni A

Publication type:

journal article

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.

Published in:

2012

By:

Nyhan MJ;
O'Donovan TR;
Elzinga B;
Crowley LC;
O'Sullivan GC;
McKenna SL;
Nyhan, M J;
O'Donovan, T R;
Elzinga, B;
Crowley, L C;
O'Sullivan, G C;
McKenna, S L

Publication type:

journal article

Sigma-2 ligands induce tumour cell death by multiple signalling pathways.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 693, doi. 10.1038/bjc.2011.602

By:

Zeng, C;
Rothfuss, J;
Zhang, J;
Chu, W;
Vangveravong, S;
Tu, Z;
Pan, F;
Chang, K C;
Hotchkiss, R;
Mach, R H

Publication type:

Article

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 673, doi. 10.1038/bjc.2011.591

By:

Brain, E;
Isambert, N;
Dalenc, F;
Diéras, V;
Bonneterre, J;
Rezai, K;
Jimenez, M;
Mefti-Lacheraf, F;
Cottura, E;
Tresca, P;
Vanlemmens, L;
Mahier-Aït Oukhatar, C;
Lokiec, F;
Fumoleau, P

Publication type:

Article

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 792, doi. 10.1038/bjc.2012.38

By:

Zeestraten, E C M;
Maak, M;
Shibayama, M;
Schuster, T;
Nitsche, U;
Matsushima, T;
Nakayama, S;
Gohda, K;
Friess, H;
van de Velde, C J H;
Ishihara, H;
Rosenberg, R;
Kuppen, P J K;
Janssen, K-P

Publication type:

Article

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 711, doi. 10.1038/bjc.2011.604

By:

Nyhan, M J;
O'Donovan, T R;
Elzinga, B;
Crowley, L C;
O'Sullivan, G C;
McKenna, S L

Publication type:

Article

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 748, doi. 10.1038/bjc.2011.587

By:

Dotan, E;
Meropol, N J;
Zhu, F;
Zambito, F;
Bove, B;
Cai, K Q;
Godwin, A K;
Golemis, E A;
Astsaturov, I;
Cohen, S J

Publication type:

Article

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 678, doi. 10.1038/bjc.2011.609

By:

Lassen, U;
Nielsen, D L;
Sørensen, M;
Winstedt, L;
Niskanen, T;
Stenberg, Y;
Pakola, S;
Stassen, J-M;
Glazer, S

Publication type:

Article

The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 685, doi. 10.1038/bjc.2012.6

By:

Follet, J;
Corcos, L;
Baffet, G;
Ezan, F;
Morel, F;
Simon, B;
Le Jossic-Corcos, C

Publication type:

Article

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 756, doi. 10.1038/bjc.2011.548

By:

Myklebust, M P;
Fluge, Ø;
Immervoll, H;
Skarstein, A;
Balteskard, L;
Bruland, O;
Dahl, O

Publication type:

Article

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 658, doi. 10.1038/bjc.2011.606

By:

Boni, C;
Tiseo, M;
Boni, L;
Baldini, E;
Recchia, F;
Barone, C;
Grossi, F;
Germano, D;
Matano, E;
Marini, G;
Labianca, R;
Di Costanzo, F;
Bagnulo, A;
Pennucci, C;
Caroti, C;
Mencoboni, M;
Zanelli, F;
Prochilo, T;
Cafferata, M A;
Ardizzoni, A

Publication type:

Article

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 629, doi. 10.1038/bjc.2011.608

By:

du Bois, A;
Vergote, I;
Wimberger, P;
Ray-Coquard, I;
Harter, P;
Curtis, L B;
Mitrica, I

Publication type:

Article

The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 702, doi. 10.1038/bjc.2011.610

By:

Dutta, S;
Going, J J;
Crumley, A B C;
Mohammed, Z;
Orange, C;
Edwards, J;
Fullarton, G M;
Horgan, P G;
McMillan, D C

Publication type:

Article

Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 763, doi. 10.1038/bjc.2011.586

By:

Tanizaki, J;
Okamoto, I;
Takezawa, K;
Sakai, K;
Azuma, K;
Kuwata, K;
Yamaguchi, H;
Hatashita, E;
Nishio, K;
Janne, P A;
Nakagawa, K

Publication type:

Article

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 740, doi. 10.1038/bjc.2011.588

By:

Konishi, H;
Ichikawa, D;
Komatsu, S;
Shiozaki, A;
Tsujiura, M;
Takeshita, H;
Morimura, R;
Nagata, H;
Arita, T;
Kawaguchi, T;
Hirashima, S;
Fujiwara, H;
Okamoto, K;
Otsuji, E

Publication type:

Article

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.

Published in:

2012

By:

Rijlaarsdam, M A;
van Herk, H A D M;
Gillis, A J M;
Stoop, H;
Jenster, G;
Martens, J;
van Leenders, G J L H;
Dinjens, W;
Hoogland, A M;
Timmermans, M;
Looijenga, L H J

Publication type:

Correction Notice

Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 619, doi. 10.1038/bjc.2011.579

By:

Tunariu, N;
Kaye, S B;
deSouza, N M

Publication type:

Article

Changes in circulating microRNA levels associated with prostate cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 768, doi. 10.1038/bjc.2011.595

By:

Bryant, R J;
Pawlowski, T;
Catto, J W F;
Marsden, G;
Vessella, R L;
Rhees, B;
Kuslich, C;
Visakorpi, T;
Hamdy, F C

Publication type:

Article

FGFR2 gene amplification and clinicopathological features in gastric cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 727, doi. 10.1038/bjc.2011.603

By:

Matsumoto, K;
Arao, T;
Hamaguchi, T;
Shimada, Y;
Kato, K;
Oda, I;
Taniguchi, H;
Koizumi, F;
Yanagihara, K;
Sasaki, H;
Nishio, K;
Yamada, Y

Publication type:

Article

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 638, doi. 10.1038/bjc.2011.552

By:

King, M T;
Viney, R;
Smith, D P;
Hossain, I;
Street, D;
Savage, E;
Fowler, S;
Berry, M P;
Stockler, M;
Cozzi, P;
Stricker, P;
Ward, J;
Armstrong, B K

Publication type:

Article

Second-line treatment for renal cell cancer.

Published in:

2012

By:

Di Lorenzo, G;
De Placido, S;
Buonerba, C

Publication type:

Editorial

Serum biomarker panels for the diagnosis of gastric adenocarcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 733, doi. 10.1038/bjc.2011.592

By:

Ahn, H S;
Shin, Y S;
Park, P J;
Kang, K N;
Kim, Y;
Lee, H-J;
Yang, H-K;
Kim, C W

Publication type:

Article

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 646, doi. 10.1038/bjc.2011.589

By:

Cella, D;
Bushmakin, A G;
Cappelleri, J C;
Charbonneau, C;
Michaelson, M D;
Motzer, R J

Publication type:

Article

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 666, doi. 10.1038/bjc.2011.590

By:

Doi, T;
Takiuchi, H;
Ohtsu, A;
Fuse, N;
Goto, M;
Yoshida, M;
Dote, N;
Kuze, Y;
Jinno, F;
Fujimoto, M;
Takubo, T;
Nakayama, N;
Tsutsumi, R

Publication type:

Article

Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 780, doi. 10.1038/bjc.2011.567

By:

Cardinale, F;
Bruzzi, P;
Bolognesi, C

Publication type:

Article

Internet chemotherapy information: impact on patients and health professionals.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 651, doi. 10.1038/bjc.2011.601

By:

Davies, E;
Yeoh, K-W

Publication type:

Article

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 775, doi. 10.1038/bjc.2011.573

By:

Sidon, L;
Ingham, S;
Clancy, T;
Clayton, R;
Clarke, A;
Jones, E A;
Lalloo, F;
Evans, D G R

Publication type:

Article

Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 719, doi. 10.1038/bjc.2011.605

By:

Ettl, T;
Baader, K;
Stiegler, C;
Müller, M;
Agaimy, A;
Zenk, J;
Kühnel, T;
Gosau, M;
Zeitler, K;
Schwarz, S;
Brockhoff, G

Publication type:

Article

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 633, doi. 10.1038/bjc.2011.593

By:

Alexandre, J;
Brown, C;
Coeffic, D;
Raban, N;
Pfisterer, J;
Mäenpää, J;
Chalchal, H;
Fitzharris, B;
Volgger, B;
Vergote, I;
Pisano, C;
Ferrero, A;
Pujade-Lauraine, E

Publication type:

Article